Quarterly Consolidated Statement Of Cash Flows

KNC Laboratories Co., Ltd. - Filing #7326866

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,071,141,000 JPY
2,428,945,000 JPY
Interest and dividends received
5,230,000 JPY
4,116,000 JPY
Interest paid
-9,795,000 JPY
-9,649,000 JPY
Income taxes paid
-870,339,000 JPY
-377,030,000 JPY
Net cash provided by (used in) operating activities
3,204,538,000 JPY
1,993,942,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,352,367,000 JPY
-1,130,212,000 JPY
Proceeds from sale of property, plant and equipment
1,150,000 JPY
27,000 JPY
Other, net
-22,263,000 JPY
-38,715,000 JPY
Net cash provided by (used in) investing activities
-2,369,133,000 JPY
-1,146,863,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,450,000,000 JPY
JPY
Repayments of long-term borrowings
-516,644,000 JPY
-439,980,000 JPY
Purchase of treasury shares
-34,000 JPY
-111,538,000 JPY
Dividends paid
-254,394,000 JPY
-271,646,000 JPY
Other, net
-59,000 JPY
-226,000 JPY
Net cash provided by (used in) financing activities
178,866,000 JPY
-523,391,000 JPY
Net increase (decrease) in cash and cash equivalents
1,014,271,000 JPY
323,687,000 JPY
Cash and cash equivalents
3,311,547,000 JPY
2,297,276,000 JPY
1,973,588,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.